SG10201508591UA - Ophthalmic solution comprising diquafosol, method for producing the same, and method for inhibiting formation of insoluble precipitate - Google Patents
Ophthalmic solution comprising diquafosol, method for producing the same, and method for inhibiting formation of insoluble precipitateInfo
- Publication number
- SG10201508591UA SG10201508591UA SG10201508591UA SG10201508591UA SG10201508591UA SG 10201508591U A SG10201508591U A SG 10201508591UA SG 10201508591U A SG10201508591U A SG 10201508591UA SG 10201508591U A SG10201508591U A SG 10201508591UA SG 10201508591U A SG10201508591U A SG 10201508591UA
- Authority
- SG
- Singapore
- Prior art keywords
- diquafosol
- producing
- same
- ophthalmic solution
- insoluble precipitate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010291463 | 2010-12-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201508591UA true SG10201508591UA (en) | 2015-11-27 |
Family
ID=46383087
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201508591UA SG10201508591UA (en) | 2010-12-28 | 2011-12-27 | Ophthalmic solution comprising diquafosol, method for producing the same, and method for inhibiting formation of insoluble precipitate |
| SG2013050000A SG191389A1 (en) | 2010-12-28 | 2011-12-27 | Ophthalmic solution containing diquafosol, method for producing the same, and method for inhibiting formation of insoluble precipitate |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2013050000A SG191389A1 (en) | 2010-12-28 | 2011-12-27 | Ophthalmic solution containing diquafosol, method for producing the same, and method for inhibiting formation of insoluble precipitate |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20140221306A1 (en) |
| EP (1) | EP2659894A4 (en) |
| JP (1) | JP2012149057A (en) |
| KR (1) | KR20140003493A (en) |
| CN (1) | CN103282039A (en) |
| AU (1) | AU2011350762B2 (en) |
| BR (1) | BR112013016008B1 (en) |
| CA (1) | CA2823148A1 (en) |
| EA (1) | EA027736B1 (en) |
| GE (1) | GEP20166448B (en) |
| MX (1) | MX2013007502A (en) |
| MY (1) | MY161032A (en) |
| SG (2) | SG10201508591UA (en) |
| TW (1) | TW201306844A (en) |
| UA (1) | UA113839C2 (en) |
| WO (1) | WO2012090994A1 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013146649A1 (en) | 2012-03-26 | 2013-10-03 | 参天製薬株式会社 | Diquafosol-containing eye drop |
| TWI709405B (en) * | 2014-12-25 | 2020-11-11 | 日商參天製藥股份有限公司 | Water-based eye drops and their applications |
| CN107635565A (en) | 2015-06-05 | 2018-01-26 | 参天制药株式会社 | The dry eye treatment agent being characterized is used in a manner of being instilled into the eye of the patients with dry eye with soft contact lens |
| EP3760207A4 (en) | 2018-02-28 | 2023-10-04 | Santen Pharmaceutical Co., Ltd. | Ophthalmic composition comprising diquafosol and cationic polymer |
| CN108853016A (en) * | 2018-09-26 | 2018-11-23 | 广州大光制药有限公司 | A kind of ophthalmic solution sodium eye drops and preparation method thereof |
| WO2020175525A1 (en) * | 2019-02-27 | 2020-09-03 | 参天製薬株式会社 | Ophthalmic composition containing diquafosol or salt thereof, vinyl-based polymer and cellulose-based polymer |
| JP6966667B2 (en) * | 2019-08-27 | 2021-11-17 | 参天製薬株式会社 | Aqueous ophthalmic composition containing diquafosol or a salt thereof, and polyvinylpyrrolidone. |
| JP7230169B2 (en) * | 2020-12-25 | 2023-02-28 | 参天製薬株式会社 | Aqueous ophthalmic solution containing diquafosol or its salt, silver salt and ionic tonicity agent |
| CN113712910A (en) * | 2021-08-05 | 2021-11-30 | 广州市桐晖药业有限公司 | Eye drops and preparation method thereof |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5900407A (en) * | 1997-02-06 | 1999-05-04 | Inspire Pharmaceuticals, Inc. | Method of treating dry eye disease with uridine triphosphates and related compounds |
| DE69822482T2 (en) | 1997-07-25 | 2005-03-03 | Inspire Pharmaceuticals, Inc. | SALTS OF DI (URIDINE 5'-TETRAPHOSPHATE), METHOD OF PREPARING THEREOF AND USES THEREOF |
| WO2001091795A1 (en) * | 2000-05-30 | 2001-12-06 | Santen Pharmaceutical Co., Ltd. | Ectocornea extension promoters |
| JP4003008B2 (en) * | 2000-05-30 | 2007-11-07 | 参天製薬株式会社 | Corneal epithelial extension promoter |
| JP2003160491A (en) * | 2001-09-11 | 2003-06-03 | Santen Pharmaceut Co Ltd | Diuridine phosphate-containing eye drop |
| JP4168071B2 (en) | 2005-12-08 | 2008-10-22 | 興和株式会社 | Ophthalmic composition |
| JP5956735B2 (en) * | 2010-09-10 | 2016-07-27 | 参天製薬株式会社 | A dry eye therapeutic agent comprising a combination of a P2Y2 receptor agonist and hyaluronic acid or a salt thereof |
-
2011
- 2011-12-27 BR BR112013016008-0A patent/BR112013016008B1/en not_active IP Right Cessation
- 2011-12-27 EP EP11852288.7A patent/EP2659894A4/en not_active Withdrawn
- 2011-12-27 US US13/976,408 patent/US20140221306A1/en not_active Abandoned
- 2011-12-27 JP JP2011285977A patent/JP2012149057A/en not_active Withdrawn
- 2011-12-27 UA UAA201309390A patent/UA113839C2/en unknown
- 2011-12-27 EA EA201390985A patent/EA027736B1/en unknown
- 2011-12-27 AU AU2011350762A patent/AU2011350762B2/en not_active Ceased
- 2011-12-27 CA CA2823148A patent/CA2823148A1/en not_active Abandoned
- 2011-12-27 WO PCT/JP2011/080179 patent/WO2012090994A1/en active Application Filing
- 2011-12-27 MX MX2013007502A patent/MX2013007502A/en unknown
- 2011-12-27 CN CN2011800632699A patent/CN103282039A/en active Pending
- 2011-12-27 GE GEAP201113176A patent/GEP20166448B/en unknown
- 2011-12-27 TW TW100148759A patent/TW201306844A/en unknown
- 2011-12-27 SG SG10201508591UA patent/SG10201508591UA/en unknown
- 2011-12-27 MY MYPI2013002461A patent/MY161032A/en unknown
- 2011-12-27 KR KR1020137019146A patent/KR20140003493A/en not_active Application Discontinuation
- 2011-12-27 SG SG2013050000A patent/SG191389A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN103282039A (en) | 2013-09-04 |
| AU2011350762B2 (en) | 2017-04-06 |
| CA2823148A1 (en) | 2012-07-05 |
| EA027736B1 (en) | 2017-08-31 |
| MY161032A (en) | 2017-04-03 |
| WO2012090994A1 (en) | 2012-07-05 |
| EP2659894A4 (en) | 2014-12-10 |
| GEP20166448B (en) | 2016-03-25 |
| EP2659894A1 (en) | 2013-11-06 |
| MX2013007502A (en) | 2013-08-01 |
| AU2011350762A1 (en) | 2013-07-25 |
| KR20140003493A (en) | 2014-01-09 |
| UA113839C2 (en) | 2017-03-27 |
| JP2012149057A (en) | 2012-08-09 |
| BR112013016008B1 (en) | 2021-06-29 |
| US20140221306A1 (en) | 2014-08-07 |
| EA201390985A1 (en) | 2013-11-29 |
| SG191389A1 (en) | 2013-07-31 |
| TW201306844A (en) | 2013-02-16 |
| BR112013016008A2 (en) | 2018-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201508591UA (en) | Ophthalmic solution comprising diquafosol, method for producing the same, and method for inhibiting formation of insoluble precipitate | |
| IL269322B (en) | Methylphenidate-prodrugs, processes of making and using the same | |
| HK1248214A1 (en) | Novel thienopyrimidine derivatives, processes for the preparation thereof and therapeutic uses thereof | |
| EP2865656A4 (en) | Method for producing glass plate having curved part, and glass plate having curved part | |
| HK1200879A1 (en) | Magnesium-aluminum-zinc alloy, method for the production thereof and use thereof | |
| HK1203073A1 (en) | Dihydrate of benzothiophene compound or of a salt thereof, and process for producing the same | |
| SG11201502284UA (en) | Method of producing a tube for use in the formation of a stent, and such tube | |
| EP2537867A4 (en) | Modified hyaluronic acid and/or salt thereof, method for producing same and cosmetic comprising same | |
| GB2509677B (en) | Method for producing medical oversleeves and production system | |
| PT2810599T (en) | Electrostimulation system for the treatment of sleep apnoea | |
| IL231677A0 (en) | Crystal of 5-hydroxy-1h-imidazole-4-carboxamide.3/4 hydrate, method for producing the same and crystal of 5-hydroxy-1h-imidazole-4-carboxamide hydrate | |
| HK1182656A1 (en) | Drug support body, and method for producing same | |
| GB2514255B (en) | Laminating system, laminating pouch, and method of manufacture | |
| PL2723743T3 (en) | 10h-benzo[g]pteridine-2,4-dione derivatives, method for the production thereof, and use thereof | |
| EP2729926A4 (en) | Wireless assessment administration system and process | |
| EP2851359A4 (en) | Method for producing 4,4''-dihydroxy-m-terphenyls | |
| EP2881137A4 (en) | Medical instrument, and medical-instrument production method | |
| EP2918614A4 (en) | Method for producing polymer, polymer solution, and polymer | |
| PL2723742T3 (en) | 10h-benzo[g]pteridine-2,4-dione derivatives, method for the production thereof, and use thereof | |
| EP2913067A4 (en) | Artificial blood vessel, and method for producing artificial blood vessel | |
| EP2885014B8 (en) | Implant and method for the production thereof | |
| PL391832A1 (en) | N-trazinylammonium salts, process for their production and the use thereof | |
| ZA201402327B (en) | Crystal of 5-hydroxy-1h-imidazole-4-carboxamide.3/4 hydrate,method for producing the same and crystal of 5-hydroxy-1h-imidazole-4-carboxamide hydrate | |
| EP2939694A4 (en) | Dialysis agent, and method for producing dialysis agent |